NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Diplomat Pharmacy, Inc. (NYSE: DPLO).
On November 2, 2016, the Company announced disappointing results for the third quarter of 2016 including earnings per share of $0.21 on revenues of $1.18 billion and lowered high end guidance for 2016 which it attributed to “softness in the hepatitis C business” and its handling of DIR fees in light of material changes in the “methodology and transparency around how PBMs are applying these DIR fees.”
Thereafter, Diplomat Pharmacy and certain of its executives were sued in a securities class action lawsuit, charging them with failing to disclose material information during the Class Period, violating federal securities laws.
KSF’s investigation is focusing on whether Diplomat Pharmacy’s officers and/or directors breached their fiduciary duties to its shareholders or otherwise violated state or federal laws.
If you have information that would assist KSF in its investigation, or have been a long-term holder of Diplomat Pharmacy shares and would like to discuss your legal rights, you may, without obligation or cost to you, call toll-free at 1-877-515-1850 or email KSF Managing Partner Lewis Kahn (email@example.com).
About Kahn Swick & Foti, LLC
KSF, whose partners include the Former Louisiana Attorney General Charles C. Foti, Jr., is a law firm focused on securities, antitrust and consumer class actions, along with merger & acquisition and breach of fiduciary litigation against publicly traded companies on behalf of shareholders. The firm has offices in New York, California and Louisiana.
To learn more about KSF, you may visit www.ksfcounsel.com.